Artificial Intelligence in Genomics Market Analysis
The Artificial Intelligence in Genomics Market is rapidly transforming the future of precision healthcare. Valued at USD 699.7 million in 2023, the market is expected to surge to USD 19,018.4 million by 2032, reflecting a robust CAGR of 44.3% over the forecast period. With the integration of AI in genomics, researchers, clinicians, and biopharmaceutical companies are unlocking unprecedented insights into genomic data analysis, disease prediction, and targeted treatment development.
One of the primary drivers fueling the growth of the Artificial Intelligence in Genomics Market is the rising demand for precision medicine. AI-powered tools enable rapid analysis of vast genomic datasets, accelerating disease gene identification and enhancing diagnostic accuracy.
Another critical factor is the integration of machine learning in genomics, which automates complex processes such as data annotation and variant classification. As healthcare systems worldwide adopt AI-based genomic software, the ability to translate genetic data into actionable insights is greatly enhanced.
Moreover, advancements in genomics technology and the decreasing cost of sequencing have further propelled market adoption. Governments and private sectors alike are investing heavily in bioinformatics platforms, AI algorithms, and predictive genomics research to stay ahead in this competitive landscape.
Get a Free Sample Report of Artificial Intelligence in Genomics Market @ https://www.snsinsider.com/sample-request/1903
Segmentation Analysis
By Component
The market is segmented into software, hardware, and services. In 2023, software held the largest market share, accounting for nearly 40% of the revenue. This segment is projected to witness the fastest growth, at a CAGR of 46.6%, due to the rising adoption of AI-based genomic software by healthcare institutions and research labs.
By Technology
In terms of technology, machine learning dominated the market in 2023, contributing around 63% of the revenue. Its utility in streamlining tasks such as genomic data processing and drug target identification makes it indispensable. Computer vision, another emerging technology, is gaining traction for its role in visual analysis of genomic sequences and has a projected CAGR of over 45%.
Regional Insights
North America
North America leads the Artificial Intelligence in Genomics Market, holding 29% of the global share in 2023. This dominance is attributed to the presence of major industry players, established biotech infrastructure, and robust funding for genomic research and development. Prominent organizations like IBM, NVIDIA, and Illumina are actively deploying AI solutions to revolutionize genomic diagnostics.
Asia Pacific
The Asia Pacific region is emerging as the fastest-growing market, with a CAGR of 47.1%. The region’s focus on national genomic initiatives, rising healthcare expenditures, and technological advancements in AI-powered genomics tools are key contributors to this explosive growth. Countries like China, India, and Thailand are heavily investing in genomic data integration platforms to facilitate personalized healthcare solutions.
Competitive Landscape
Leading companies are strategically investing in AI in genomics platforms to gain a competitive edge. Key players include:
IBM, Microsoft Corporation, NVIDIA Corporation – AI Platforms
Deep Genomics, Data4Cure, Freenome Holdings – Genomic Data Analysis
Thermo Fisher Scientific, Illumina, Inc. – Genomic Sequencing
SOPHiA GENETICS, BenevolentAI, Fabric Genomics – Data Interpretation
Recent Developments
May 2024: The EXPRESSO model was launched to predict autoimmune disease risks using genomic and epigenetic datasets, improving early detection.
Feb 2023: Accenture Ventures invested in Ocean Genomics, enhancing AI-driven computational platforms for biopharma diagnostics and therapeutics.
Market Opportunities
The growing need for personalized medicine, combined with AI’s capability to decipher complex genetic information, opens new avenues for targeted drug discovery, genomic risk assessment, and disease prevention.
Investments in next-generation sequencing and bioinformatics infrastructure are expected to create scalable platforms for AI-driven healthcare innovation across clinical settings and pharmaceutical R&D.
Challenges
Despite rapid progress, challenges such as data privacy, regulatory compliance, and the high cost of implementation may hamper market scalability. Ethical concerns surrounding AI decision-making in genomic research also require clear guidelines and oversight.
Buy a Single-User PDF of Artificial Intelligence in Genomics Market Analysis & Outlook Report 2024-1903 @ https://www.snsinsider.com/checkout/1903
Conclusion
The Artificial Intelligence in Genomics Market is at the forefront of a healthcare revolution. As AI continues to unlock the power of human genetics, stakeholders across biotech, healthcare, and life sciences are poised to benefit from improved diagnostics, targeted therapies, and accelerated research outcomes.
With robust investments, rapid technological evolution, and a focus on genomic data analysis, the global AI in genomics market is on track to redefine the future of personalized medicine.
Read Our Other Report
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave – Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
